Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $513.82 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $190.73 | 3 | $0 (2024) |
| Mylan Specialty L.P. | $82.18 | 1 | $0 (2023) |
| PFIZER INC. | $71.02 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $67.23 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $42.07 | 2 | $0 (2024) |
| ABBVIE INC. | $34.82 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $25.77 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $366.42 | 10 | Mallinckrodt Hospital Products Inc. ($190.73) |
| 2023 | $130.72 | 3 | Mylan Specialty L.P. ($82.18) |
| 2019 | $16.68 | 1 | AstraZeneca Pharmaceuticals LP ($16.68) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Rare Disease | ||||||
| 08/06/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: CRITICAL CARE | ||||||
| 06/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/30/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $136.02 | General |
| Category: CRITICAL CARE | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: CRITICAL CARE | ||||||
| 02/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/16/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Rare Disease | ||||||
| 10/26/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2023 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $82.18 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/18/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 401 | 817 | $231,089 | $59,417 |
| 2022 | 5 | 441 | 859 | $246,631 | $55,891 |
| 2021 | 3 | 173 | 364 | $107,500 | $24,391 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 223 | 633 | $178,813 | $41,460 | 23.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 155 | 161 | $40,495 | $15,536 | 38.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $11,781 | $2,422 | 20.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 239 | 643 | $182,287 | $37,512 | 20.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 134 | 139 | $39,028 | $12,060 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 32 | 33 | $17,166 | $3,711 | 21.6% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 18 | 26 | $4,770 | $1,532 | 32.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 18 | 18 | $3,380 | $1,076 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 103 | 292 | $82,828 | $17,686 | 21.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 58 | 60 | $18,300 | $5,330 | 29.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $6,372 | $1,375 | 21.6% |
About Dr. Dileep Kumar, M.D
Dr. Dileep Kumar, M.D is a Nephrology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821542630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dileep Kumar, M.D has received a total of $513.82 in payments from pharmaceutical and medical device companies, with $366.42 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($513.82).
As a Medicare-enrolled provider, Kumar has provided services to 1,015 Medicare beneficiaries, totaling 2,040 services with total Medicare billing of $139,700. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Student in an Organized Health Care Education/Training Program, Hospitalist
- Location Bronx, NY
- Active Since 08/09/2016
- Last Updated 07/12/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1821542630
Products in Payments
- TERLIVAZ (Drug) $190.73
- Yupelri (Drug) $82.18
- ENTRESTO (Drug) $67.23
- ELIQUIS (Drug) $46.08
- TEFLARO (Drug) $34.82
- SOLIRIS (Biological) $25.77
- ANDEXXA (Biological) $25.39
- VYNDAQEL (Drug) $24.94
- LOKELMA (Drug) $16.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bronx
Dr. Bruce Spinowitz, M.d, M.D
Nephrology — Payments: $510,667
Joel Neugarten, Md, MD
Nephrology — Payments: $384,806
Enver Akalin, M.d, M.D
Nephrology — Payments: $76,364
John He, Md, MD
Nephrology — Payments: $24,885
Abdurhman Ahmed, M.d, M.D
Nephrology — Payments: $12,466
Dr. Suman Reddy, Md, MD
Nephrology — Payments: $7,783